bhukap

Total Rating:
0 / 0

1 Comment

    • Fri Nov 2nd 18:05 PM | Rating: 0 0
      Commented on:
      Jim Cramer's Mad Money In-Depth. 11/1/07: Brocade Saddles Up
      Kramer keeps supporting Celgene but the news is out on its only two drugs, Revlimid and Thalidomide both of limited use outside of myeloma and some uncommon blood disorders. Its stock is in my judgment very overpriced. I own 5000 shares of Millenium and I am a happy camper today. I am also an oncologist and find Celgene's pricing for its drugs and its corporate behavior outrageous. Remember Velcade is IV and revlimid is po. Given equivalency which do you think an oncologist would choose?
      View article »
Contribute an Article Become a Seeking Alpha Contributor